Federal award
BIOMERIEUX INC
W81K0223P0128
Contract
Obligated and Ceiling
- Obligated (net)
- $534,007.98
- Ceiling (potential value, not spending)
- $534,007.98
- Current value
- $534,007.98
- Gross positive obligations
- $669,107.44
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BIOMERIEUX INC · HCNVCMEG9NL6
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0223P0128
- Award type code
- B
- Actions
- 9 · Sep 26, 2023 to May 2, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 2, 2026 | FY2026 | P00008 | M | $0.00 | — |
| Apr 9, 2026 | FY2026 | P00007 | M | $0.00 | — |
| Apr 17, 2025 | FY2025 | P00006 | B | −$96,769.92 | — |
| Nov 6, 2024 | FY2025 | P00005 | C | $295,457.85 | — |
| Sep 24, 2024 | FY2024 | P00004 | G | $0.00 | — |
| Aug 1, 2024 | FY2024 | P00003 | B | −$38,329.54 | — |
| Nov 3, 2023 | FY2024 | P00002 | C | $373,649.59 | — |
| Oct 26, 2023 | FY2024 | P00001 | M | $0.00 | — |
| Sep 26, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.